Clinical Trial Update: Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of secukinumab in active psoriatic arthritis with axial skeleton involvement has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Psoriatic Arthritis
• Psoriatic Arthritis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Axial Psoratic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-08-24